The FDA approved updated COVID-19 shots from Pfizer, Moderna, and Novavax. The agency approved the vaccines for adults 65 and older. Younger people at high risk for severe COVID-19 are also eligible, ...

As if you needed another health concern to worry about — beyond the “explosive diarrhea” stomach parasite causing a surge of sicknesses around the United States — the COVID-19 virus has made a ...

Tesla has effectively sold out its 2026 Model Y allocation for Canada — and we're still in July. Every variant is now showing delivery estimates at the tail end of 2026 or sliding into early 2027, a ...

Genomic divergence in BA.3.2 exceeds prior major strain shifts, producing marked reductions in serum neutralization from current vaccine-induced antibodies. Biological constraints may be limiting BA.3 ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Federal funding cuts for one of America's major infectious disease ...

The FDA's vaccine advisors will meet Thursday to vote on whether an XFG monovalent vaccine should be preferred for COVID-19 shots for the 2026-2027 season. The Vaccines and Related Biological Products ...

A highly mutated COVID-19 strain is circulating — raising concerns that disease activity could rise heading into the summer. The emergence of the BA.3.2 strain, nicknamed "cicada," comes amid broader ...

The “cicada” SARS-CoV-2 variant, which earned its nickname after staying relatively dormant following its discovery in 2024, has accounted for a small proportion of COVID-19 cases since the CDC began ...

A highly mutated COVID-19 strain is circulating in California — raising concerns that disease activity could rise heading into the summer. The emergence of the BA.3.2 strain, nicknamed "Cicada," comes ...

Canadian visits to the United States fell 21% in 2025 — the equivalent of 4.2 million fewer visitors and $4.5 billion in lost spending — and data from the first months of 2026 show the decline ...